Trial intelligence / Profile preview

PK of Azithromycin Eye Drops in Healthy Volunteers

NCT03235141Phase 1Unknown

Sponsor
Beijing Tongren Hospital
Start
Jul 2017
Primary completion
Oct 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, open-label trial of AzaSite in bacterial conjunctivitis (BC) (2 arms), sponsored by Beijing Tongren Hospital. Primary endpoint: Area Under the Curve from time 0 to time t at 36 hours. Status: unknown.

02

Drugs

AzaSite
03

Conditions

bacterial conjunctivitis (BC)

Beyond the preview

Go deeper on NCT03235141.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03235141.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call